Delivery Order SPE2DR25D7061-SPE2DR26F7WPJ
- Not listed
- On June 13, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,321.41 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by June 16, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,152.72 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under an existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.75 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,554.28. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $4,705.66. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competed award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No small business...
- The Defense Logistics Agency awarded a delivery order valued at $7,595.87 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials. The contract, awarded on November 10, 2025, carries a firm fixed price structure with an ultimate completion date of November 12, 2025. The award represents a competitive procurement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,939.34 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The Defense Logistics Agency awarded a $3,943.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes. This non-set-aside contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7WPJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $1,721.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is set for ultimate completion by November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medical products to support federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The naloxone procurement supports critical emergency medical needs within the military healthcare supply chain, consistent with the company's extensive portfolio of pharmaceutical and medical device deliveries to defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/18/25 |